Stony Brook, NY4 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Stony Brook, NY

Find 4 actively recruiting myalgic encephalomyelitis clinical trials in Stony Brook, NY. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
190
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Stony Brook

About Myalgic Encephalomyelitis Clinical Trials in Stony Brook

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 4 myalgic encephalomyelitis clinical trials recruiting participants in Stony Brook, NY. These studies are seeking a combined 190 participants. Research is being sponsored by West-Ward Pharmaceutical, Stony Brook University, Marie Badalamente. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Stony Brook — FAQ

Are there myalgic encephalomyelitis clinical trials in Stony Brook?

Yes, there are 4 myalgic encephalomyelitis clinical trials currently recruiting in Stony Brook, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stony Brook?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stony Brook research site will contact you about next steps.

Are clinical trials in Stony Brook free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stony Brook studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 4 active trials in Stony Brook are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 22, 2026 from ClinicalTrials.gov